Skip to main content

Performance characteristics of an automated assay for the quantitation of CYFRA 21-1 in human serum.

Patel JL, Erickson JA, Roberts WL, Grenache DG

Publication: Clin Biochem (2010) • Vol 43 • Page 1449-52PMID: 20875814View on PubMed

Purpose

The purpose of this paper was to evaluate the stability and sensitivity of cytoleratin 19 fragment 21-1 (CYFRA 21-1) in serum as a marker for non-small cell lung cancer (NSCLC).

Conclusion

CYFRA 21-1 was stable in serum for more than 48 h in specimens stored at room temperature and more than 14 days in specimens stored at 4 degrees C regardless of concentration. The sensitivity of CYFRA 21-1, as determined by the ability to diagnose NSCLC, increased with NSCLC tumor stage. In stage II-IV NSCLC tumors, CYFRA 21-1 alone was more sensitive than SCCa and CEA combined. The use of either SCCa and/or CEA with CYFRA 21-1 increased the sensitivity.

Studies (1)

Purpose

The purpose of this study was to evaluate the stability of CYFRA 21-1 in serum specimens and compare the sensitivity of CYFRA 21-1, squamous cell carcinoma antigen (SCCa), and carcinoembryonic antigen (CEA) as markers for non-small cell lung cancer (NSCLC). After experimental storage specimens were stored for up to 1 week at 4-8 degrees C or for more than 1 week at -20 degrees C.

Summary of Findings

CYFRA 21-1 was stable in serum for more than 48 h in specimens stored at room temperature and more than 14 days in specimens stored at 4 degrees C regardless of concentration. Gender and age had no effects on CYFRA 21-1 levels. The sensitivity of CYFRA 21-1 increased with NSCLC tumor stage. A slight increase in sensitivity with tumor stage was also observed for CEA, but not SCCa. In stage II-IV NSCLC tumors, CYFRA 21-1 alone was more sensitive than SCCa and CEA combined. The use of either SCCa or CEA with CYFRA 21-1 increased the sensitivity. The combination of all three markers resulted in the highest sensitivity.

  • Biospecimens

    FluidSerum
    FluidBlood
  • Preservation Types

    Frozen
  • Diagnoses

    Normal
    NeoplasticCarcinoma
  • Platforms

    ProteinClinical chemistry/auto analyzer
    ProteinELISA
    PeptideClinical chemistry/auto analyzer
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionBiomarker level
    0.9 ng/mL CYFRA 21-1
    18.2 ng/mL CYFRA 21-1
    36.2 ng/mL CYFRA 21-1
    54.1 ng/mL CYFRA 21-1
    71.4 ng/mL CYFRA 21-1
    PreaquisitionPatient age
    19-60 years
    PreaquisitionPatient gender
    Female
    Male
    StorageStorage duration
    0 h
    10 days
    14 days
    16 h
    2 days
    24 h
    4 days
    4 h
    48 h
    7 days
    8 h
    StorageStorage temperature
    4 degrees C
    Room temperature
    Clinical chemistry/auto analyzer SpecificTargeted peptide/protein
    Carcinoembryonic antigen (CEA)
    Cytoleratin 19 fragment 21-1 (CYFRA 21-1)
    Squamous cell carcinoma antigen (SCCa)